Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

1.0K
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
1.0K
Renal Drug Excretion: Overview01:15

Renal Drug Excretion: Overview

869
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
869
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

993
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
993
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

869
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
869
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

3.7K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.7K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

297
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
297

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tacrolimus intrapatient variability and latent virus reactivation after kidney transplantation: A retrospective study comparing prolonged-release and immediate-release tacrolimus formulations.

The Journal of international medical research·2026
Same author

Evaluation of Endothelial Dysfunction in Geriatric Patients with Non-Dialysis Chronic Kidney Disease.

Journal of clinical medicine·2026
Same author

Effects of intradialytic resistance versus flexibility exercises on clinical outcomes in hemodialysis patients: a pilot randomized controlled trial.

BMC nephrology·2026
Same author

Pregnancy and its outcomes in hemodialysis patients in Turkey.

Turkish journal of medical sciences·2026
Same author

Comment on "Dialysis versus conservative kidney management in older adults: why one size does not fit all".

International urology and nephrology·2026
Same author

Glycaemic control and complications in haemodialysis patients: the TURK-HEMODIAB Study.

Clinical kidney journal·2026

Related Experiment Video

Updated: Mar 7, 2026

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

2.0K

Synthetic cannabinoids in the kidneys.

Alper Alp1, Hakan Akdam2, Banu Yılmaz Avcıoğlu1

  • 1Nephrology, Tepecik Education and Research Hospital, Izmir, Turkey.

Revista Da Associacao Medica Brasileira (1992)
|February 23, 2017
PubMed
Summary

Acute kidney injury (AKI) is a significant health concern. Emerging nephrotoxic agents, particularly from substance abuse among youth, contribute to AKI, increasing mortality and morbidity.

More Related Videos

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

2.2K
Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging
04:33

Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging

Published on: December 8, 2023

1.5K

Related Experiment Videos

Last Updated: Mar 7, 2026

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

2.0K
Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

2.2K
Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging
04:33

Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging

Published on: December 8, 2023

1.5K

Area of Science:

  • Nephrology
  • Toxicology
  • Public Health

Background:

  • Acute kidney injury (AKI) is a critical global health issue, contributing significantly to mortality and morbidity.
  • Etiological factors for AKI are diverse and evolving with changes in time, geography, and living conditions.
  • Increasing prevalence of substance abuse, particularly among younger populations, has heightened concerns regarding nephrotoxic effects.

Purpose of the Study:

  • To investigate the emerging nephrotoxic agents contributing to acute kidney injury.
  • To raise awareness regarding the link between substance abuse and kidney damage in young individuals.
  • To understand the changing landscape of AKI etiological factors.

Main Methods:

  • Literature review of recent studies on AKI.
  • Analysis of epidemiological data on substance abuse and kidney health.
  • Case study analysis of nephrotoxicity from addictive substances.

Main Results:

  • Identified several novel nephrotoxic agents associated with substance abuse.
  • Demonstrated a correlation between increased substance use and AKI incidence in specific demographics.
  • Highlighted the need for targeted interventions for at-risk populations.

Conclusions:

  • Substance abuse represents a growing threat for acute kidney injury, especially in young populations.
  • Continuous monitoring and research into emerging nephrotoxic agents are crucial.
  • Public health strategies should address substance abuse to mitigate AKI burden.